Gankyrin promotes the proliferation of human pancreatic cancer

Cancer Letters

Volumn 297, Issue 1, 2010, Pages 9-17

  Meng, Yun ^a   He, Lijie ^a   Guo, Xuegang ^a   Tang, Shanhong ^a   Zhao, Xiaodi ^a   Du, Rui ^a   Jin, Jiang ^a   Bi, Qian ^a   Li, Hao ^a   Nie, Yongzhan ^a   liu, Jie ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Gankyrin; Pancreatic cancer; Proliferation

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; CYCLINE; GANKYRIN; ONCOPROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG; CCND1 PROTEIN, HUMAN; CDK2 PROTEIN, HUMAN; CDK4 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEASOME; PSMD10 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE; GENETIC TRANSFECTION; GENETICS; METABOLISM; MIDDLE AGED; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; PHOSPHORYLATION; RNA INTERFERENCE; TIME; TUMOR CELL LINE;

ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN A; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 77956230794     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.04.019     Document Type: Article

References (27)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J. Clin. 2009, 59:225-249.
2. Mendieta Zeron H., Garcia Flores J.R., Romero Prieto M.L. Limitations in improving detection of pancreatic adenocarcinoma. Future Oncol. 2009, 5:657-668.
3. Wong H.H., Lemoine N.R. Pancreatic cancer: molecular pathogenesis and new therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 2009, 6:412-422.
4. Hori T., Kato S., Saeki M., DeMartino G.N., Slaughter C.A., Takeuchi J., Toh-e A., Tanaka K. CDNA cloning and functional analysis of p28 (Nas6p) and p40.5 (Nas7p), two novel regulatory subunits of the 26S proteasome. Gene 1998, 216:113-122.
5. Yuan C., Li J., Mahajan A., Poi M.J., Byeon I.J., Tsai M.D. Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure-function relationship. Biochemistry 2004, 43:12152-12161.
6. Manjasetty B.A., Quedenau C., Sievert V., Bussow K., Niesen F., Delbruck H., Heinemann U. X-ray structure of human gankyrin, the product of a gene linked to hepatocellular carcinoma. Proteins 2004, 55:214-217.
7. Fu X.Y., Wang H.Y., Tan L., Liu S.Q., Cao H.F., Wu M.C. Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance. World J. Gastroenterol. 2002, 8:638-643.
8. Umemura A., Itoh Y., Itoh K., Yamaguchi K., Nakajima T., Higashitsuji H., Onoue H., Fukumoto M., Okanoue T., Fujita J. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma. Hepatology 2008, 47:493-502.
9. Iwai A., Marusawa H., Kiuchi T., Higashitsuji H., Tanaka K., Fujita J., Chiba T. Role of a novel oncogenic protein, gankyrin, in hepatocyte proliferation. J. Gastroenterol. 2003, 38:751-758.
10. Ortiz C.M., Ito T., Tanaka E., Tsunoda S., Nagayama S., Sakai Y., Higashitsuji H., Fujita J., Shimada Y. Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance. Int. J. Cancer 2008, 122:325-332.
11. Tang S., Yang G., Meng Y., Du R., Li X., Fan R., Zhao L., Bi Q., Jin J., Gao L., Zhang L., Li H., Fan M., Wang Y., Wu K., Liu J., Fan D. Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer. Cancer Biol. Ther. 2010, 9:1-8.
12. Dawson S., Apcher S., Mee M., Higashitsuji H., Baker R., Uhle S., Dubiel W., Fujita J., Mayer R.J. Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome. J. Biol. Chem. 2002, 277:10893-10902.
13. Dawson S., Higashitsuji H., Wilkinson A.J., Fujita J., Mayer R.J. Gankyrin: a new oncoprotein and regulator of pRb and p53. Trends Cell Biol. 2006, 16:229-233.
14. Chen J. Establishment and studies of two human pancreatic carcinoma in vivo lines by transplanting the tumor into nude mice. Chinese J. Pathol. 1989, 18:197-200.
15. Pan Y., Bi F., Liu N., Xue Y., Yao X., Zheng Y., Fan D. Expression of seven main Rho family members in gastric carcinoma. Biochem. Biophys. Res. Commun. 2004, 315:686-691.
16. van Golen K.L., Wu Z.F., Qiao X.T., Bao L.W., Merajver S.D. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res. 2000, 60:5832-5838.
17. Liu N., Bi F., Pan Y., Sun L., Xue Y., Shi Y., Yao X., Zheng Y., Fan D. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin. Cancer Res. 2004, 10:6239-6247.
18. Jin H., Pan Y., Zhao L., Zhai H., Li X., Sun L., He L., Chen Y., Hong L., Du Y., Fan D. P75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells. Neoplasia 2007, 9:471-478.
19. He L., Wang H., Jin H., Guo C., Xie H., Yan K., Li X., Shen Q., Qiao T., Chen G., Chai N., Zhao L., Dong Q., Zheng Y., Liu J., Fan D. CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma. Cancer Lett. 2009, 276:88-94.
20. Li X., Zhang Y., Xiong C., Jin H., Jing B., Fan D. Overexpression of a new gene P28GANK confers multidrug resistance of gastric cancer cells. Cancer Invest. 2009, 27:129-139.
21. Chen X., Zhang M., Liu L.X. The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells. Oncol. Rep. 2009, 22:73-80.
22. Maddika S., Ande S.R., Panigrahi S., Paranjothy T., Weglarczyk K., Zuse A., Eshraghi M., Manda K.D., Wiechec E., Los M. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist. Updat. 2007, 10:13-29.
23. Lundberg A.S., Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 1998, 18:753-761.
24. Ohtsubo M., Theodoras A.M., Schumacher J., Roberts J.M., Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 1995, 15:2612-2624.
25. Pagano M., Pepperkok R., Verde F., Ansorge W., Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 1992, 11:961-971.
26. Miller F.D., Kaplan D.R. Neurotrophin signalling pathways regulating neuronal apoptosis. Cell. Mol. Life Sci. 2001, 58:1045-1053.
27. Sherr C.J. The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell Biol. 2001, 2:731-737.